Dr. David Farrell, clinical professor of surgery at OHSU and founder and Chief Scientific Officer at Gamma Diagnostics Inc., shares his poster and abstract at the American Heart Association meeting. COVID-19 patients can develop extremely high levels of gamma prime fibrinogen (GPF) which has several important clinical implications relative to administration of anticoagulants and steroids. Click here to read more.
Search
Recent Posts
See AllStay tuned for an exciting Covid-19 study and a newly identified thrombosis biomarker to be presented at the American Heart Association meeting on Nov 13th by our founder, Dr. David Farrell, Professo
180
We are happy to announce Gamma Diagnostics joined Expert DOJO's September 2021 #healthcare accelerator program. With their healthcare industry expertise, they are giving 110% to transform the healthc
14